Hazim S Ababneh
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 17, 2024
Post-CAR T-Cell Therapy Failure Metabolic Parameters Predict Survival and Response in Large B-Cell Lymphoma.Hazim S Ababneh, Matthew J Frigault, Andrea K Ng
|Dec 09, 2024
Breaking Traditions: Evaluating Single Fraction Radiation in Indolent Lymphoma.Hazim S Ababneh, Chirayu G Patel
|Jun 11, 2024
Radiotherapy as a bridging strategy for patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy.Hazim S Ababneh, Andrea K Ng, Matthew J Frigault
|Dec 16, 2023
Radiation therapy as bridging and salvage strategy among patients with secondary central nervous system lymphoma undergoing CD19-targeted chimeric antigen receptor T-cell therapy.Hazim S Ababneh, Matthew J Frigault, Andrea K Ng
|Oct 05, 2023
Metabolic parameters predict survival and toxicity in chimeric antigen receptor T-cell therapy-treated relapsed/refractory large B-cell lymphoma.Hazim S Ababneh, Andrea K Ng, Jeremy S Abramson
|Sep 08, 2023
Radiation therapy for patients with relapsed or refractory mantle cell lymphoma undergoing CD19-targeted chimeric antigen receptor T-cell therapy.Hazim S Ababneh, Matthew J Frigault, Chirayu G Patel
Pageof 2
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=75)
